ArticleEmerging infectious diseases2015
Antibodies against Borrelia burgdorferi sensu lato among Adults, Germany, 2008-2011.
Article in Emerging infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 9 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
48 citing papers in PubMed, 9 syntheses or guidelines pooled it.
- Guidelines for diagnosis and treatment in neurology - Lyme neuroborreliosis.German medical science : GMS e-journal · 2025Guideline
- Cutaneous Lyme borreliosis: Guideline of the German Dermatology Society.German medical science : GMS e-journal · 2025Guideline
- Seroprevalence of Lyme Borreliosis in Europe: Results from a Systematic Literature Review (2005-2020).Vector borne and zoonotic diseases (Larchmont, N.Y.) · 2023Pooled it
- Systematic Review and Meta-analysis of Lyme Disease Data and Seropositivity for Borrelia burgdorferi, China, 2005‒2020.Emerging infectious diseases · 2022Pooled it
- Global seroprevalence and sociodemographic characteristics ofBMJ global health · 2022Pooled it
- Guidelines for diagnosis and treatment in neurology - Lyme neuroborreliosis.German medical science : GMS e-journal · 2020Guideline
- Lyme Neuroborreliosis.Deutsches Arzteblatt international · 2018Pooled it
- [Neuroborreliosis - Diagnostics, treatment and course].Der Nervenarzt · 2017Pooled it
- Cutaneous Lyme borreliosis: Guideline of the German Dermatology Society.German medical science : GMS e-journal · 2017Guideline
- Risk Factors for Tick-Borne Diseases in Germany: A Scoping Review.Zoonoses and public health · 2026Article
- Repeated cross-sectional surveys show a decreasing trend inEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025Article
- Modelling the impact of climate and the environment on the spatiotemporal dynamics of Lyme borreliosis in Germany.EBioMedicine · 2025Article
- Incidence of symptomatic Borrelia burgdorferi sensu lato infection in Romania, 2018-2023.Parasites & vectors · 2024Article
- Serological Assessment ofPathogens (Basel, Switzerland) · 2024Article
- A serosurvey examining exposure toIJID regions · 2024Article
- Seropositivity of Borrelia burgdorferi s.l. in Germany-an analysis across four German National Cohort (NAKO) study sites.Scientific reports · 2023Article
- Seroprevalence forEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2023Article
- Seroprevalence, seroconversion and seroreversion ofEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2023Article
- [Bacterial zoonoses of public health importance in Germany-incidence, distribution, and modes of transmission].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2023Review
- The AxBioTick Study:Microorganisms · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To assess Borrelia burgdorferi sensu lato (the cause of Lyme borreliosis) seropositivity in Germany, we tested serum samples from health survey (2008-2011) participants. Seroprevalence was 5.8% among women and 13.0% among men; infection risk was highest among persons >60 years of age. Public health interventions, including education about risk factors and preventive measures, are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.